fantazzyd,
It's all in their anns in B&W.
Capitalised at 198M shares, up from 192M therefore approx 6M extra shares.
$750K next drawdown will be approx 7.5M shares making total cap approx 207M shares.
If they can manage a licensing deal in the mean time and pull of an initial licensing fee from the pharma(s) this will inject much needed capital to get NF off the ground.
I also take it that you sold NAL huh?
- Forums
- ASX - By Stock
- NAL
- line of credit
line of credit, page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)